Stocks
Editas Medicine (EDIT) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -47.0% | -27.8% | -33.4% | -56.7% | -43.9% | -119.9% | ||
| Changes by years, y/y, % | 0pp | +19pp | -6pp | -23pp | +13pp | -1.2% | |||
Editas Medicine. ROE, %
Editas Medicine. ROE, changes, pp
Editas Medicine (EDIT) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -51.6% | -42.9% | -56.4% | -83.4% | -119.9% | -119.9% | |
| Changes by years, y/y, % | -4pp | +16pp | +9pp | -35pp | -68pp | |||
| Changes by quarters, q/q, % | -3pp | +9pp | -14pp | -27pp | -37pp | |||
